Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22185371)

  • 1. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
    Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
    BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
    Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
    Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.
    Sun S; Wong TS; Zhang XQ; Pu JK; Lee NP; Day PJ; Ng GK; Lui WM; Leung GK
    J Neurooncol; 2012 Mar; 107(1):89-100. PubMed ID: 21979894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
    Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
    Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
    Pérès EA; Gérault AN; Valable S; Roussel S; Toutain J; Divoux D; Guillamo JS; Sanson M; Bernaudin M; Petit E
    Oncotarget; 2015 Feb; 6(4):2101-19. PubMed ID: 25544764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
    Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
    Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance.
    Kitange GJ; Carlson BL; Schroeder MA; Decker PA; Morlan BW; Wu W; Ballman KV; Giannini C; Sarkaria JN
    J Neurooncol; 2010 Nov; 100(2):177-86. PubMed ID: 20443131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
    Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
    Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma.
    Schäfer A; Teufel J; Ringel F; Bettstetter M; Hoepner I; Rasper M; Gempt J; Koeritzer J; Schmidt-Graf F; Meyer B; Beier CP; Schlegel J
    Neuro Oncol; 2012 Dec; 14(12):1452-64. PubMed ID: 23132408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.
    Zhang N; Wu X; Yang L; Xiao F; Zhang H; Zhou A; Huang Z; Huang S
    Clin Cancer Res; 2012 Nov; 18(21):5961-71. PubMed ID: 22977194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.
    Wu J; Liu Y; Cho K; Dong X; Teng L; Han D; Liu H; Chen X; Chen X; Hou X; Peng F; Bi Y; Shen C; Zhao S
    Neuroreport; 2016 Feb; 27(3):136-44. PubMed ID: 26716385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of EGFRvIII in glioblastoma: prognostic significance revisited.
    Montano N; Cenci T; Martini M; D'Alessandris QG; Pelacchi F; Ricci-Vitiani L; Maira G; De Maria R; Larocca LM; Pallini R
    Neoplasia; 2011 Dec; 13(12):1113-21. PubMed ID: 22241957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.
    Zhang Z; Wang Y; Chen J; Tan Q; Xie C; Li C; Zhan W; Wang M
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1289-1296. PubMed ID: 27832326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF
    Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.